Table 2.
Clinicopathological characteristics of the patients.
| Feature | Number of patients (%) | |
|---|---|---|
| Patients enrolled | 153 | |
| Age | <40 | 10 (6.5) |
| 40–60 | 88 (57.5) | |
| >60 | 55 (36) | |
| Histology type | ||
| Ductal | 104 (68) | |
| Lobular | 9 (6) | |
| Other | 40 (26) | |
| Tumor size | ||
| T1 | 39 (25) | |
| T2 | 87 (57) | |
| T3-4 | 24 (16) | |
| Unknown | 3 (2) | |
| Lymph-node status | ||
| Node-negative | 58 (38) | |
| Node-positive | 75 (49) | |
| Unknown | 20 (13) | |
| Histopathological grade | ||
| I + II | 49 (32) | |
| III | 57 (37) | |
| Not analyzed | 47 (31) | |
| Estrogen receptor (ER) | ||
| Positive (>20 fmol/mg) | 55 (36) | |
| Negative (≤20 fmol/mg) | 98 (64) | |
| Progesterone receptor (PgR) | ||
| Positive (>20 fmol/mg) | 40 (26) | |
| Negative (≤20 fmol/mg) | 113 (73) | |
| ErbB2 | ||
| Positive (>260 ng/mg) | 81 (53) | |
| Negative (≤260 ng/mg) | 72 (47) | |